Origimm is developing safe therapies that are effective in the long-term, because they are addressing the root cause of the disease, not only treating the symptoms. Our approach is enabling us to develop breakthrough therapies for the prevention and treatment of skin microbiome-associated diseases, such as acne vulgaris.
